PHENYLBUTYRATE CO-DEVELOPMENT AND SUBLICENSE AGREEMENT BY AND AMONG BRIDGE THERAPEUTIC PRODUCTS, INC AND BRIDGE ONCOLOGY PRODUCTS, INC.Sublicense Agreement • July 19th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT (the “Agreement”), is made and effective as of February 16, 2005 (the “Effective Date”), by and between Bridge Therapeutic Products Inc. (“BTP”) and Bridge Oncology Products Inc. (“BOP” and, together with BTP, the “Parties”).
AGREEMENT REGARDING ACADEMIC CLINICAL STUDY BETWEEN THE CANCER RESEARCH INSTITUTE OF CONTRA COSTA AND SOMANTA LIMITEDAgreement Regarding Academic Clinical Study • July 19th, 2006 • Somanta Pharmaceuticals Inc. • Pharmaceutical preparations • California
THIS AGREEMENT REGARDING ACADEMIC CLINICAL STUDY (the “Agreement”) is entered into as of August 18, 2005 (the “Effective Date”) by and between SOMANTA LIMITED, a corporation organized under the laws of England (“Somanta”), and THE CANCER RESEARCH INSTITUTE OF CONTRA COSTA, a non-profit research institution (“CRICC”), each individually referred to in this Agreement as a “Party” and both collectively as the “Parties”.
